Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Farmers Insurance
Julphar
Chubb
Chinese Patent Office
Covington
Moodys
McKinsey
Dow

Generated: June 20, 2018

DrugPatentWatch Database Preview

INTROPIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Intropin patents expire, and when can generic versions of Intropin launch?

Intropin is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in INTROPIN is dopamine hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
Summary for INTROPIN
Drug patent expirations by year for INTROPIN
Medical Subject Heading (MeSH) Categories for INTROPIN
Synonyms for INTROPIN
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
(3H)-Dopamine
1, 4-(2-aminoethyl)-
1,2-Benzenediol, 4-(2-aminoethyl)-
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
1,2-Benzenediol, 4-(2-aminoethyl)-(9CI)
13510-EP2269989A1
13510-EP2270011A1
13510-EP2272537A2
13510-EP2272825A2
13510-EP2272847A1
13510-EP2275420A1
13510-EP2277882A1
13510-EP2280010A2
13510-EP2281559A1
13510-EP2281815A1
13510-EP2281819A1
13510-EP2284169A1
13510-EP2284170A1
13510-EP2284171A1
13510-EP2286811A1
13510-EP2287161A1
13510-EP2287162A1
13510-EP2287165A2
13510-EP2287166A2
13510-EP2292620A2
13510-EP2295437A1
13510-EP2295439A1
13510-EP2298312A1
13510-EP2298313A1
13510-EP2298731A1
13510-EP2298734A2
13510-EP2298758A1
13510-EP2298759A1
13510-EP2298775A1
13510-EP2298776A1
13510-EP2301540A1
13510-EP2301933A1
13510-EP2305260A1
13510-EP2305633A1
13510-EP2305640A2
13510-EP2305644A1
13510-EP2305648A1
13510-EP2305650A1
13510-EP2305652A2
13510-EP2305656A1
13510-EP2305659A1
13510-EP2305664A1
13510-EP2305675A1
13510-EP2305689A1
13510-EP2308828A2
13510-EP2308867A2
13510-EP2308870A2
13510-EP2308875A1
13510-EP2311494A1
13510-EP2311801A1
13510-EP2311802A1
13510-EP2311803A1
13510-EP2311818A1
13510-EP2311827A1
13510-EP2311828A1
13510-EP2311835A1
13510-EP2314571A2
13510-EP2316470A2
13510-EP2316836A1
13510-EP2371814A1
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3, 4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl) ethylamine
2-(3,4-Dihydroxyphenyl)-1-ethanamine
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine3,4-dihydroxyphenethylamine3-hydroxytyramine; DA; Intropin; Revivan; Oxytyramine
2-(4-Hydroxy-5-oxylatophenyl)-1-ethanaminium
2-benzenediol
3- HYDROXYTYRAMINE
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine HCl salt
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3B1-005775
4-(2-Amino-ethyl)-benzene-1,2-diol
4-(2-Aminoethyl)-1
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol #
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-aminoethyl)pyrocatechol;hydrochloride
4-(2-azanylethyl)benzene-1,2-diol;hydrochloride
4CH-018780
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AB00053463_13
AB00053463_14
AB00053463-12
AC1L19S5
AC1Q54AX
AC1Q54AY
AJ-08579
AK100905
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
AN-41611
ANW-54385
ASL 279
BBL013043
BDBM55121
BIDD:ER0506
Biomol-NT_000001
bmse000909
bmse000933
BP-23276
BPBio1_001123
BSPBio_001932
C03758
CAS-51-61-6
CCG-204675
CHEBI:18243
CHEMBL59
cid_65340
cMAP_000036
cMAP_000065
CTK4E3164
D07870
D0T7OW
DB00988
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dophamine
DSSTox_CID_2420
DSSTox_GSID_22420
DSSTox_RID_76584
DTXSID6022420
EINECS 200-110-0
FT-0698513
GTPL940
HSDB 3068
Hydroxytyramin
hydroxytyramine
IDI1_000780
Intropin (Salt/Mix)
Intropin [*hydrochloride*]
IP 498
KB-237403
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
Lopac-H-8502
Lopac0_000586
LS-159
m-Hydroxytyramine-
MCULE-7558764100
Medopa (TN)
MFCD00130258
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-02
NCGC00015519-03
NCGC00015519-04
NCGC00015519-05
NCGC00015519-07
NCGC00015519-08
NCGC00015519-09
NCGC00015519-10
NCGC00015519-11
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC-173182
NSC169105
NSC173182
Oprea1_088821
OR040702
OR176618
OR274736
Oxytyramine
PHENOXY, 4-(2-AMINOETHYL)-2-HYDROXY-
Pyrocatechol, 4-(2-aminoethyl)-
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Pyrocatechol, 4-(2-aminoethyl)-(8CI)
Revimine
SBB004044
SBI-0050568.P004
SCHEMBL8505
Sinemet
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
ST2405321
STK301601
T7923
Tox21_110167
Tox21_110167_1
TX-016804
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
VTD58H1Z2X
VYFYYTLLBUKUHU-UHFFFAOYSA-N
ZINC33882

US Patents and Regulatory Information for INTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira INTROPIN dopamine hydrochloride INJECTABLE;INJECTION 017395-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira INTROPIN dopamine hydrochloride INJECTABLE;INJECTION 017395-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira INTROPIN dopamine hydrochloride INJECTABLE;INJECTION 017395-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Farmers Insurance
Fuji
UBS
Merck
Cantor Fitzgerald
Mallinckrodt
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.